Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib

Clinical trial NCT06548867 · RECRUITING

Trial details

NCT number: NCT06548867
Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
Status: RECRUITING
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma

Start date: 2024-05-28
Primary completion: 2025-06-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.